Lubna Qamar Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2011	TRAIL receptor signaling regulation of chemosensitivity in vivo but not in vitro.
4/2007	Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lubna Qamar Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 04/2007
6	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 09/2008
2	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 03/2016
2	Neoplasm Metastasis (Metastasis) 05/2012 - 04/2007
1	VLCAD deficiency 09/2019
1	Circulating Neoplastic Cells 01/2017
1	Ovarian Epithelial Carcinoma 11/2015
1	Breast Neoplasms (Breast Cancer) 11/2015
1	Lymphoma (Lymphomas) 01/2011
1	Inflammation (Inflammations) 03/2008
1	Edema (Dropsy) 03/2008
1	Body Weight (Weight, Body) 03/2008
1	Erythema 03/2008
1	Carcinoma (Carcinomatosis) 04/2007
1	Carcinogenesis 04/2007

Drug/Important Bio-Agent (IBA)

2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 09/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2008
2	Keratins (Keratin)IBA 01/2017 - 11/2015
2	Cisplatin (Platino)FDA LinkGeneric 11/2015 - 09/2008
2	Messenger RNA (mRNA)IBA 05/2012 - 04/2007
2	Proteins (Proteins, Gene)FDA Link 05/2012 - 01/2011
2	LigandsIBA 01/2011 - 04/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011 - 04/2007
1	lorecivivintIBA 01/2021
1	CateninsIBA 01/2021
1	beta CateninIBA 01/2021
1	etomoxirIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 11/2019
1	Adiponectin ReceptorsIBA 11/2019
1	AdipoRonIBA 11/2019
1	Sirolimus (Rapamycin)FDA Link 11/2019
1	AMP-Activated Protein KinasesIBA 11/2019
1	SuspensionsIBA 09/2019
1	LipidsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Progestins (Progestagens)IBA 03/2016
1	Estrogen ReceptorsIBA 11/2015
1	Keratin-5 (Keratin 5)IBA 11/2015
1	Homeodomain Proteins (Proteins, Homeobox)IBA 05/2012
1	Fas Ligand Protein (Fas Ligand)IBA 01/2011
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2011
1	Transcription Factors (Transcription Factor)IBA 01/2011
1	Death Domain ReceptorsIBA 01/2011
1	Caffeine (No Doz)FDA LinkGeneric 09/2008
1	Protein Kinase CIBA 09/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2008
1	Free RadicalsIBA 03/2008
1	4-O-carboxymethylascochlorinIBA 03/2008
1	bucillamine (SA 96)IBA 03/2008
1	Biological ProductsIBA 03/2008
1	CyclinsIBA 04/2007
1	AntibodiesIBA 04/2007

Therapy/Procedure

2	Therapeutics 11/2015 - 04/2007
2	Drug Therapy (Chemotherapy) 11/2015 - 09/2008